Evidence from mouse models suggests that mutant Kras can contribute to PDA initiation by reprogramming acinar cells into a duct like lineage capable of becoming PanINs via a process termed acinar to ductal metaplasia (ADM) [4], [5], [6]. The gene discussed is KRAS; the disease is Patent ductus arteriosus.